Literature DB >> 22349341

Current applications of high-resolution mass spectrometry in drug metabolism studies.

Markus R Meyer1, Hans H Maurer.   

Abstract

This paper reviews high-resolution mass spectrometry (HRMS) approaches published in 2007-2011 for the elucidation of drug metabolism with a focus on new therapeutics, new drugs of abuse, and doping agents using time-of-flight, single-stage Orbitrap, ion trap Orbitrap, and other Fourier transform MS-based techniques. The present review provides an overview of metabolite-generating systems and assays used, sample preparation techniques, ionization and fragmentation techniques, as well as data mining strategies and software tools which were used in the reviewed papers. Furthermore, HRMS-specific topics such as demand for a certain resolution or a specific mass accuracy are discussed in detail and corresponding recommendations are given. Finally, the advantages and limitations of these methods are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349341     DOI: 10.1007/s00216-012-5807-z

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  9 in total

Review 1.  Metabolomic signature of brain cancer.

Authors:  Renu Pandey; Laura Caflisch; Alessia Lodi; Andrew J Brenner; Stefano Tiziani
Journal:  Mol Carcinog       Date:  2017-07-17       Impact factor: 4.784

Review 2.  Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

Authors:  Michael H Baumann; Mohammad O Bukhari; Kurt R Lehner; Sebastien Anizan; Kenner C Rice; Marta Concheiro; Marilyn A Huestis
Journal:  Curr Top Behav Neurosci       Date:  2017

Review 3.  Therapeutic drug monitoring for tomorrow.

Authors:  Erik Eliasson; Jonatan D Lindh; Rickard E Malmström; Olof Beck; Marja-Liisa Dahl
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

4.  In silico, in vitro, and in vivo human metabolism of acetazolamide, a carbonic anhydrase inhibitor and common "diuretic and masking agent" in doping.

Authors:  Francesco P Busardò; Alfredo F Lo Faro; Ascanio Sirignano; Raffaele Giorgetti; Jeremy Carlier
Journal:  Arch Toxicol       Date:  2022-04-11       Impact factor: 6.168

5.  The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood.

Authors:  Mark A Marzinke; Autumn Breaud; Teresa L Parsons; Myron S Cohen; Estelle Piwowar-Manning; Susan H Eshleman; William Clarke
Journal:  Clin Chim Acta       Date:  2014-03-22       Impact factor: 3.786

6.  Mass Spectrometry Applications for Toxicology.

Authors:  Michael M Mbughuni; Paul J Jannetto; Loralie J Langman
Journal:  EJIFCC       Date:  2016-12-01

7.  High-throughput quantification of carboxymethyl lysine in serum and plasma using high-resolution accurate mass Orbitrap mass spectrometry.

Authors:  Naomi J Rankin; Karl Burgess; Stefan Weidt; Goya Wannamethee; Naveed Sattar; Paul Welsh
Journal:  Ann Clin Biochem       Date:  2019-03-04       Impact factor: 2.057

8.  Identification of the metabolites of ivermectin in humans.

Authors:  Phornpimon Tipthara; Kevin C Kobylinski; Markus Godejohann; Borimas Hanboonkunupakarn; Alison Roth; John H Adams; Nicholas J White; Podjanee Jittamala; Nicholas P J Day; Joel Tarning
Journal:  Pharmacol Res Perspect       Date:  2021-02

9.  Metabolite Identification and Pharmacokinetic Behavior of Diaveridine in the Plasma of Pigs and Chickens Based on Radioactive Tracing Coupled With LC/MS-IT-TOF Assay.

Authors:  Liye Wang; Lihua Wen; Yuanhu Pan; Zhenzhen Wang; Kaixiang Zhou; Kun Mi; Zhenli Liu; Wei Qu; Lingli Huang
Journal:  Front Vet Sci       Date:  2022-01-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.